ASTM F2721

ASTM F2721 is a technical guide focused on preclinical in vivo evaluation in critical-size segmental bone defects. It provides a structured reference for assessing bone repair performance in living test models, helping support more consistent study design and interpretation. As an ASTM standard, it is relevant to teams that need a common basis for evaluating regenerative materials, implants, or related bone-healing approaches before broader use.

What is ASTM F2721?

ASTM F2721 is the Standard Guide for Preclinical in vivo Evaluation in Critical-Size Segmental Bone Defects. It is intended to guide how these evaluations are approached, with attention to the preclinical setting and the specific challenge of a critical-size segmental defect. The standard is useful for organizing study expectations around how bone-healing performance is assessed, without overstating clinical outcomes. In practice, ASTM F2721 supports a more consistent technical framework for planning and reviewing these animal-based studies.

Where is ASTM F2721 used?

This standard is commonly used in preclinical research settings where bone-regeneration strategies are being evaluated in living models. It is relevant to organizations working with bone repair devices, biomaterials, scaffolds, or other technologies intended to support healing in segmental defects. ASTM F2721 may also be used by development teams and testing groups that need a recognized guide for study planning, comparison, and documentation in a controlled research workflow.

Why is ASTM F2721 important?

ASTM F2721 helps bring clarity and consistency to preclinical evaluation of a demanding bone-defect model. That matters because study methods, endpoints, and reporting approach can affect how results are interpreted and compared. Using a recognized ASTM standard can support better internal quality control, smoother procurement decisions, and more reliable technical communication between research, development, and review teams. For products aimed at bone repair, it provides a practical benchmark for evaluation.

• Preclinical in vivo evaluation guidance
• Critical-size segmental bone defect focus
• Study planning and review reference
• Bone repair and regeneration assessment
• Consistency in technical evaluation